Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed Jul 18, 2025 · 10-K · 565 days after period end · 0001640334-25-001245
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $360.00K | $598.00K | $0.00 |
| Net Income | -$18.24K | -$3.93M | -$3.85M | -$61.77K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Jul 18, 2025 · 565 d after period end
